» Articles » PMID: 21442356

Gli1 Enhances Migration and Invasion Via Up-regulation of MMP-11 and Promotes Metastasis in ERα Negative Breast Cancer Cell Lines

Overview
Specialty Oncology
Date 2011 Mar 29
PMID 21442356
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Gli1 is an established oncogene and its expression in Estrogen Receptor (ER) α negative and triple negative breast cancers is predictive of a poor prognosis; however, the biological functions regulated by Gli1 in breast cancer have not been extensively evaluated. Herein, Gli1 was over-expressed or down-regulated (by RNA interference and by expression of the repressor form of Gli3) in the ERα negative, human breast cancer cell lines MDA-MB-231 and SUM1315. Reduced expression of Gli1 in these two cell lines resulted in a decrease in migration and invasion. Gli1 over-expression increased the migration and invasion of MDA-MB-231 cells with a corresponding increase in expression of MMP-11. Silencing MMP-11 in MDA-MB-231 cells that over-expressed Gli1 abrogated the Gli1-induced enhancement of migration and invasion. Sustained suppression of Gli1 expression decreased growth of MDA-MB-231 in vitro by increasing apoptosis and decreasing proliferation. In addition, silencing of Gli1 reduced the numbers and sizes of pulmonary metastases of MDA-MB-231 in an in vivo experimental metastasis assay. In summary, Gli1 promotes the growth, survival, migration, invasion and metastasis of ERα negative breast cancer. Additionally, MMP-11 is up-regulated by Gli1 and mediates the migration and invasion induced by Gli1 in MDA-MB-231.

Citing Articles

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.

Liu Y, Zou Y, Ye Y, Chen Y Cancer Med. 2024; 13(22):e70410.

PMID: 39558881 PMC: 11574469. DOI: 10.1002/cam4.70410.


Matrix Metalloproteinase 11 Promotes Migration and Invasion of Colorectal Cancer by Elevating Slug Protein.

Pan C, Dai J, Wei Y, Yang L, Ding Z, Wang X Int J Med Sci. 2024; 21(11):2170-2188.

PMID: 39239548 PMC: 11373555. DOI: 10.7150/ijms.98007.


The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells.

Graf S, Haybaeck J, Behre G, Kalinski T, Nass N Contemp Oncol (Pozn). 2023; 26(4):294-305.

PMID: 36816389 PMC: 9933353. DOI: 10.5114/wo.2023.125000.


Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics.

Subhan M RSC Adv. 2022; 12(51):32956-32978.

PMID: 36425155 PMC: 9670683. DOI: 10.1039/d2ra02005j.


Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).

Ko Y, Choi H, Liu R, Lee D Int J Mol Sci. 2021; 22(16).

PMID: 34445421 PMC: 8395918. DOI: 10.3390/ijms22168718.


References
1.
Kameda C, Tanaka H, Yamasaki A, Nakamura M, Koga K, Sato N . The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. Anticancer Res. 2009; 29(3):871-9. View

2.
Sadlonova A, Mukherjee S, Bowe D, Gault S, Dumas N, Van Tine B . Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease. Am J Pathol. 2007; 170(3):1064-76. PMC: 1864888. DOI: 10.2353/ajpath.2007.060031. View

3.
Fiorentino M, Fu L, Shi Y . Mutational analysis of the cleavage of the cancer-associated laminin receptor by stromelysin-3 reveals the contribution of flanking sequences to site recognition and cleavage efficiency. Int J Mol Med. 2009; 23(3):389-97. PMC: 2643359. DOI: 10.3892/ijmm_00000143. View

4.
Louro I, Bailey E, Li X, South L, Yoder B, Huang C . Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res. 2002; 62(20):5867-73. View

5.
Ahmad A, Hanby A, Dublin E, Poulsom R, Smith P, Barnes D . Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am J Pathol. 1998; 152(3):721-8. PMC: 1858384. View